Ranbaxy - Latest News on Ranbaxy | Read Breaking News on Zee News

`Ranbaxy got USFDA nod with no data or fraudulent data`

Last Updated: Thursday, November 07, 2013, 19:05

India`s drug major Ranbaxy Laboratories used "fraudulent" data to get USFDA nod to sell its generic drugs, according to whistleblower Dinesh Thakur, who has also accused the drug-maker of faking test results.

Ranbaxy whistle-blower says drug maker faked data

Last Updated: Thursday, November 07, 2013, 18:51

An Indian origin whistle-blower, who exposed a massive fraud by the Indian pharmaceutical giant Ranbaxy, has accused the generic drug maker of faking test results for approval by the US drug regulator.

Ranbaxy gets CDSCO nod to sell malaria drug `SynriamTM`

Last Updated: Monday, October 21, 2013, 13:40

Drug major Ranbaxy Laboratories Monday said it has received Indian drug regulator`s approval to market SynriamTM for treating malaria caused by Plasmodium vivax parasite.

Ranbaxy `systematically violated` good manufacturing practices: Whistleblower

Last Updated: Tuesday, May 14, 2013, 20:49

Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India`s top drugmaker agreed to pay a hefty USD 500 million to settle charges over its adulterated drugs.

Ranbaxy resumes supply of Atorvastatin tablets in US market

Last Updated: Monday, April 01, 2013, 15:44

Drug major Ranbaxy Laboratories today said it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, in the US market.

Ranbaxy to sell generic anti-depression drug in US

Last Updated: Wednesday, March 06, 2013, 11:20

The US arm of Indian drug major Ranbaxy Laboratories has entered into an in-licensing agreement with Alembic Pharmaceuticals Limited to exclusively market the generic version of Pfizer Inc.`s anti-depression drug Pristiq in the US.

Ranbaxy stops production of its generic Lipitor: USFDA

Last Updated: Saturday, December 01, 2012, 11:11

Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor.

Ranbaxy launches generic diabetes drug in US

Last Updated: Friday, August 17, 2012, 18:04

Ranbaxy Laboratories today said it has launched generic pioglitazone hydrochloride tablets used for treating diabetes in the American market.

First Prev 1 2 Next Last